Current status of intensity-modulated radiation therapy (IMRT)

Kazuo Hatano1, Hitoshi Araki, Mitsuhiro Sakai

  • 1Division of Radiation Oncology, Chiba Cancer Center, Chiba, Japan. khatano@chiba-cc.jp

Summary

Intensity-modulated radiation therapy (IMRT) offers higher prostate cancer radiation doses with fewer side effects. Achieving optimal IMRT plans requires careful balancing of target coverage and organ sparing through detailed treatment planning.

Related Concept Videos